Investigation on the Mechanisms of <i>Zanthoxylum bungeanum</i> for Treating Diabetes Mellitus Based on Network Pharmacology, Molecular Docking, and Experiment Verification

<div>Molecular docking of IL-6 with 5 main ingredients: (a) kokusaginin, (b) skimmianin, (c) diosmetin, (d) beta-sitosterol, and (e) quercetin, respectively.</div>

BioMed Research International

fig8

Figure 8

Figure 8: Investigation on the Mechanisms of <i>Zanthoxylum bungeanum</i> for Treating Diabetes Mellitus Based on Network Pharmacology, Molecular Docking, and Experiment Verification 

Figure 8 | Investigation on the Mechanisms of Zanthoxylum bungeanum for Treating Diabetes Mellitus Based on Network Pharmacology, Molecular Docking, and Experiment Verification 